Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up 0.12% Nasdaq Up 0.51%
Streaming
Ticker Tape: On

Alkermes plc (ALKS)

-NasdaqGS
44.35 Down 0.68(1.51%) 3:23PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:45.03
Open:44.78
Bid:44.37 x 200
Ask:44.41 x 100
1y Target Est:50.73
Beta:1.39
Next Earnings Date:N/A
Day's Range:44.08 - 45.72
52wk Range:26.47 - 54.25
Volume:814,930
Avg Vol (3m):1,364,640
Market Cap:6.39B
P/E (ttm):277.19
EPS (ttm):0.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSDown 1.51%6.39B
ABTUp 1.54%60.13B
LLYUp 0.64%64.38B
GSKDown 0.45%125.96B

Key Statistics

Forward P/E (1 yr):58.41
P/S (ttm):11.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.50
Quarterly EPS Est (Mar-14) :0.10
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):3.06

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback